QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 akili-says-endeavorotc-is-the-only-fda-authorized-digital-therapeutic-for-adhd-available-without-a-prescription

Delivered through an engaging video game experience, EndeavorOTC is indicated to improve attention function as measured by comp...

 akili-q1-2024-adj-eps-012-beats-014-estimate-sales-38300k-miss-79400k-estimate

Akili (NASDAQ:AKLI) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 14.2...

 akili-announces-amended-agreement-with-shionogi-shionogi-has-canceled-and-forgiven-a-5m-long-term-debt-obligation-and-agreed-to-make-certain-payments-for-sdt-001-the-japanese-localized-version-of-akilis-akl-t01-digital-treatment-marketed-as-endeavorrx-in-the-us

Shionogi amendment provides Akili with near-term cash payments and cancellation of debt obligationCompany announces exploration...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION